Your browser is unsupported

We recommend using the latest version of IE11, Edge, Chrome, Firefox or Safari.

Photo of Michael Buege

Array Array Array, Array

Array

Array

Pronouns: Array

Contact

Building & Room:

Array

Address:

Array

Office Phone:

Array

Fax:

Array

Office Phone TTY:

Array

Array

Building & Room:

Array

Address:

Array

Office Phone:

Array

Office Phone TTY:

Array

Email:

Array

Related Sites:

Hematology/Oncology (PHAR 509), 1/13/2025 – 5/7/2025
Evidence-Based Medicine (PHAR 440), 2/12/2024 – 4/30/2024
Hematology/Oncology (PHAR 509), 1/8/2024 – 4/26/2024
Evidence-Based Medicine (PHAR 440), 2/13/2023 – 4/28/2023
Evidence-Based Medicine (PHAR 440), 2/13/2023 – 4/28/2023

About

Array

Selected Publications

Merrill, Mwanasha H, Redd, Robert A, Lambert, Nicholas, Caimi, Paolo F, Pullarkat, Priyanka, Godby, Richard C, Bond, David A, Wehmeyer, Graham T, Romancik, Jason, Amoozgar, Behzad, Leslie, Lori, Nastoupil, Loretta J, Crombie, Jennifer L, Abramson, Jeremy S, Khurana, Arushi, Nowakowski, Grzegorz S, Maddocks, Kami, Rutherford, Sarah C, Kahl, Brad, Okwali, Michelle, Buege, Michael J, Batlevi, Connie L, Armand, Philippe, Salles, Gilles, Qualls, David A. (2025). Outcomes of tafasitamab and lenalidomide in large B‐cell lymphoma based on prior CD19‐directed CAR T exposure. HemaSphere, 9, (11), e70253. doi:10.1002/hem3.70253.

Qualls, David A, Lambert, Nicholas, Caimi, Paolo F, Merrill, Mwanasha, Pullarkat, Priyanka, Godby, Richard C, Bond, David A, Wehmeyer, Graham T, Romancik, Jason, Amoozgar, Behzad, Leslie, Lori, Nastoupil, Loretta J, Crombie, Jennifer L, Abramson, Jeremy S, Khurana, Arushi, Nowakowski, Grzegorz S, Maddocks, Kami, Rutherford, Sarah C, Kahl, Brad, Okwali, Michelle, Buege, Michael J, Seshan, Venkatraman, Batlevi, Connie L, Salles, Gilles. (2023). Tafasitamab and lenalidomide in large B-cell lymphoma: real-world outcomes in a multicenter retrospective study. Blood, 142, (26), 2327-2331. doi:10.1182/blood.2023021274.

Villa, Diego, Jiang, Aixiang, Visco, Carlo, Crosbie, Nicola, McCulloch, Rory, Buege, Michael J, Kumar, Anita, Bond, David A, Paludo, Jonas, Maurer, Matthew J, Thanarajasingam, Gita, Lewis, Katharine Louise, Cheah, Chan Yoon, Baech, Joachim, Galaly, Tarec C El, Kugathasan, Laveniya, Scott, David W, Gerrie, Alina S, Lewis, David. (2023). Time to progression of disease and outcomes with second-line BTK inhibitors in relapsed/refractory mantle cell lymphoma. Blood Advances, 7, (16), 4576-4585. doi:10.1182/bloodadvances.2023009804.

Sawalha, Yazeed, Goyal, Subir, Switchenko, Jeffrey M, Romancik, Jason T, Kamdar, Manali, Greenwell, Irl Brian, Hess, Brian T, Isaac, Krista M, Portell, Craig A, Garcia, Alex V Mejia, Goldsmith, Scott R, Grover, Natalie S, Riedell, Peter A, Karmali, Reem, Burkart, Madelyn, Buege, Michael, Akhtar, Othman S, Torka, Pallawi, Kumar, Anita, Hill, Brian T, Kahl, Brad S, Cohen, Jonathon B. (2023). A Multicenter Analysis of the Outcomes with Venetoclax in Patients with Relapsed Mantle Cell Lymphoma. Blood Advances, 7, (13), 2983-2993. doi:10.1182/bloodadvances.2022008916.

Buege, Michael J, Drill, Esther, Horwitz, Steven M, LeVoir, Andréa, Pak, Terry, Peterson, Tim J, Dao, Phuong H, Matasar, Matthew J. (2023). Low incidence of cardiotoxicity in patients with non‐Hodgkin lymphoma receiving EPOCH after prior anthracycline exposure. European Journal Of Haematology, 111, (1), 96-102. doi:10.1111/ejh.13971.

King, Amber, Land, Josiah, Liu, Dazhi, Peterson, Tim, Reiss, Samantha, Vadakkel, Grashma, Eng, Stephen, Pak, Terry, Daukshus, Nicole, Spatz, Krisoula, LeVoir, Andrea, Buege, Michael, Weis, Taylor, Gutierrez, Jillian. (2022). Cancer Pharmacology. Pocket Oncology.

Pak, Terry K, Dixon, Brianne N, Buege, Michael J, Dao, Phuong H, Leary, Megan H, Jarrett, Joy C, Duggan, Tara A, Caron, Philip, Falchi, Lorenzo, Hamlin, Paul, Hamilton, Audrey, Matasar, Matthew J, Moskowitz, Alison, Noy, Ariela, Owens, Colette N, Von Keudell, Gottfried, Younes, Anas, Zelenetz, Andrew D, Kumar, Anita. (2022). Successful implementation of outpatient R ± DHAX (rituximab, dexamethasone, oxaliplatin, cytarabine) for select patients with lymphoma: a single-center experience. Leukemia & Lymphoma, 63, (4), 876-884. doi:10.1080/10428194.2021.2002318.

Buege, Michael J, Dao, Phuong H, Drill, Esther, LeVoir, Andréa, Pak, Terry, Peterson, Tim J, Straus, David J. (2021). IVAC With or Without Rituximab for Relapsed or Refractory B-Cell Non-Hodgkin Lymphomas: Real-World Experience in the Modern Era. Clinical Lymphoma Myeloma & Leukemia, 21, (12), 873-878. doi:10.1016/j.clml.2021.07.024.

Yerram, Prakirthi, Thackray, Jennifer, Modelevsky, Lisa R, Land, Josiah D, Reiss, Samantha N, Spatz, Krisoula H, Levoir, Andrea C, Pak, Terry K, Dao, Phuong H, Buege, Michael J, Derespiris, Lauren M, Lau, Carmen, Orozco, Jennifer S, Boparai, Manpreet, Koranteng, Lauren A, Reichert, Kate E, Yan, Shirley Q, Daukshus, Nicole P, Mathew, Sherry, Buie, Larry W, Tizon, Richard F, Freeswick, Scott, Liu, Dazhi, Harnicar, Stephen. (2021). Outpatient clinical pharmacy practice in the face of COVID-19 at a cancer center in New York City. Journal of Oncology Pharmacy Practice, 27, (2), 389-394. doi:10.1177/1078155220987625.

Service to Community

Array

Professional Leadership

Oral Chemotherapy Collaborative, Hematology Oncology Pharmacy Association, 6/1/2023 - 5/31/2025

Education

Array

Licensures and Certifications

Array

Professional Memberships

Array

Selected Presentations

Array

Research Currently in Progress

Array

Intellectual Property

Array

Artistic and Professional Performances and Exhibits

Array